Serotonergic descending inhibitory pain pathway

The serotonergic descending inhibitory pain pathway is a major endogenous system responsible for the top-down modulation of nociceptive processing within the spinal cord (StatPearls, 2023). It originates in the brainstem, primarily within the rostral ventromedial medulla (RVM) and the nucleus raphe magnus, receiving inputs from the periaqueductal gray (PAG) (Bannister & Dickenson, 2017). These neurons project to the spinal dorsal horn, where they release serotonin (5-HT) to modulate the activity of primary afferent fibers and second-order projection neurons (Ossipov et al., 2014). While serotonin can have complex effects, the inhibitory component is largely mediated by 5-HT1 and 5-HT7 receptors, which reduce the release of excitatory neurotransmitters like glutamate and substance P (Marks et al., 2009). Impairment of this pathway is strongly linked to the development and maintenance of chronic pain conditions, including fibromyalgia and neuropathic pain, where descending facilitation often outweighs inhibition (Stahl, 2013). Therapeutic strategies focus on enhancing serotonergic tone using Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) and Tricyclic Antidepressants (TCAs) to restore normal pain signaling thresholds (PubMed, 2020).

Other names

Descending serotonergic systemBulbospinal serotonergic pathwayEndogenous pain modulation systemDescending inhibitory control

Enhancement of synaptic serotonin levels in the spinal cord dorsal horn via reuptake inhibition, leading to the activation of inhibitory 5-HT receptors (e.g., 5-HT1A, 5-HT7) on nociceptive neurons.